ICCB280 T8839
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
CAS nr:
2041072-41-5
Purity:
98%
Molecular Weight:
386,4
SMILES:
O=C1N(C2=CC=CC=C2OC)C(/C=C/C3=CC=C(O)C(O)=C3)=NC4=C1C=CC=C4
Formula:
C23H18N2O4
Pathway:
Others,Apoptosis
Target:
Others,Apoptosis
